5-Lipoxygenase in monocytes emerges as a therapeutic target for intimal hyperplasia in a murine wire-injured femoral artery

Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2210-2219. doi: 10.1016/j.bbadis.2017.06.012. Epub 2017 Jun 20.

Abstract

Given the importance of leukotrienes in vascular inflammation induced by local tissue injury, this study investigated the role for 5-lipoxygenase (5-LO) in monocytes in the development of intimal hyperplasia. As a mechanistic study, the importance of monocyte 5-LO in monocyte-macrophage differentiation with subsequent infiltration in neointima was evaluated. In a mouse model of wire-injured femoral artery, intimal hyperplasia started as early as 2wks after injury, and luminal area and blood flow were reduced due to increased neointima formation. Time-dependent increases in macrophage infiltration were observed in neointima and showed a positive relationship with neointima volume. In 5-LO-deficient (KO) mice or wild-type (WT) mice treated with an inhibitor of 5-LO activating protein (MK886, 1 and 10mg/kg), intimal hyperplasia and macrophage infiltration into neointima were reduced, but monocyte adhesion to injured luminal surface was not inhibited, which suggested 5-LO participates in monocyte-macrophage differentiation. In an in vitro study, monocyte-macrophage differentiation was found to be increased by high mobility group box 1 protein (HMGB1), but this effect was attenuated in cells isolated from 5-LO-KO mice. Furthermore, macrophage infiltration and intimal hyperplasia were more prominent in 5-LO-KO mice transplanted with monocytes from WT mice than in 5-LO-KO mice transplanted with monocytes from 5-LO-KO mice. Taken together, it was suggested that 5-LO in monocytes played a pivotal role in monocyte-macrophage differentiation and subsequent infiltration of macrophage in neointima, leading to vascular remodeling after vascular injury.

Keywords: 5-Lipoxygenase; High mobility group box 1 protein; Monocyte-macrophage differentiation; Restenosis; Vascular remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonate 5-Lipoxygenase / genetics
  • Arachidonate 5-Lipoxygenase / metabolism*
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Femoral Artery* / enzymology
  • Femoral Artery* / injuries
  • Femoral Artery* / pathology
  • HMGB1 Protein / genetics
  • HMGB1 Protein / metabolism
  • Hyperplasia
  • Indoles / pharmacology*
  • Lipoxygenase Inhibitors / pharmacology*
  • Macrophages / enzymology*
  • Macrophages / pathology
  • Mice
  • Mice, Knockout
  • Monocytes / enzymology*
  • Monocytes / pathology
  • Neointima* / drug therapy
  • Neointima* / enzymology
  • Neointima* / pathology
  • Tunica Intima / enzymology
  • Tunica Intima / pathology
  • Vascular Remodeling / drug effects
  • Vascular Remodeling / genetics

Substances

  • HMGB1 Protein
  • HMGB1 protein, mouse
  • Indoles
  • Lipoxygenase Inhibitors
  • MK-886
  • Arachidonate 5-Lipoxygenase